Form 4: Edgewise Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Joanne M. Donovan, CMO of Edgewise Therapeutics, Inc., sold 9,441 shares of common stock on August 12, 2026.
Summary
- Option exercise/conversion: acquired 5,781 Common Stock on August 12, 2026; holds 11,035 after (Direct).
- Option exercise/conversion: acquired 7,031 Common Stock on August 12, 2026; holds 18,066 after (Direct).
- Open-market sale: disposed of 2,839 Common Stock at $43.78 ($124,303) on August 12, 2026; holds 15,227 after (Direct).
- Open-market sale: disposed of 2,779 Common Stock at $43.71 ($121,463) on August 12, 2026; holds 12,448 after (Direct).
- Open-market sale: disposed of 104 Common Stock at $44.43 ($4,620) on August 12, 2026; holds 12,344 after (Direct).
- Open-market sale: disposed of 800 Common Stock at $44.52 ($35,614) on August 12, 2026; holds 11,544 after (Direct).
- Open-market sale: disposed of 2,919 Common Stock at $43.41 ($126,704) on August 13, 2026; holds 8,625 after (Direct).
- Option exercise/conversion: disposed of 5,781 Restricted Stock Units on August 12, 2026; holds 11,563 after (Direct).
- Option exercise/conversion: disposed of 7,031 Restricted Stock Units on August 12, 2026; holds 21,094 after (Direct).
- Grant/award: acquired 32,500 Restricted Stock Units on August 12, 2026; holds 32,500 after (Direct).
- Grant/award: acquired 65,000 Stock Option (Right to Buy) on August 12, 2026; holds 65,000 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $412,703 of stock on the open market.
Insider Transactions
Joanne M. Donovan — Officer (CMO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-12 | Option exercise/conversion | Common Stock | 5,781 | — | — | 11,035 |
| 2026-08-12 | Option exercise/conversion | Common Stock | 7,031 | — | — | 18,066 |
| 2026-08-12 | Open-market sale | Common Stock | 2,839 | $44 | $124.3K | 15,227 |
| 2026-08-12 | Open-market sale | Common Stock | 2,779 | $44 | $121.5K | 12,448 |
| 2026-08-12 | Open-market sale | Common Stock | 104 | $44 | $4.6K | 12,344 |
| 2026-08-12 | Open-market sale | Common Stock | 800 | $45 | $35.6K | 11,544 |
| 2026-08-13 | Open-market sale | Common Stock | 2,919 | $43 | $126.7K | 8,625 |
| 2026-08-12 | Option exercise/conversion | Restricted Stock Units | 5,781 | — | — | 11,563 |
| 2026-08-12 | Option exercise/conversion | Restricted Stock Units | 7,031 | — | — | 21,094 |
| 2026-08-12 | Grant/award | Restricted Stock Units | 32,500 | — | — | 32,500 |
| 2026-08-12 | Grant/award | Stock Option (Right to Buy) | 65,000 | — | — | 65,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-12 | Option exercise/conversion (5,781 shares) |
| 2026-08-12 | Option exercise/conversion (7,031 shares) |
| 2026-08-12 | Open-market sale (2,839 shares) |
| 2026-08-12 | Open-market sale (2,779 shares) |
| 2026-08-12 | Open-market sale (104 shares) |
| 2026-08-12 | Open-market sale (800 shares) |
| 2026-08-13 | Open-market sale (2,919 shares) |
| 2026-08-12 | Option exercise/conversion (5,781 shares) |
| 2026-08-12 | Option exercise/conversion (7,031 shares) |
| 2026-08-12 | Grant/award (32,500 shares) |
| 2026-08-12 | Grant/award (65,000 shares) |
Keywords
insider transaction, Form 4, EWTX, Edgewise Therapeutics, Inc., bearish, Joanne M. Donovan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.